Pfizer (PFE) closed at $27.99 in the latest trading session, marking a -1.3% move from the prior day.
Novavax (NVAX) seeks marketing authorization in the European Union for an updated version of its COVID-19 vaccine, which has been formulated to target the JN.1 variant.
This is a matchup that the latecomer might not be able to win.